A drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers, according to a recent study by Harvey J. Murff, MD, MPH, and colleagues.
Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.
Vanderbilt investigators have conducted a prospective multicenter study on how extracorporeal photopheresis works in treating chronic graft-versus-host disease (cGVHD) — a complication of bone marrow or stem cell transplant that occurs when donor cells attack the recipient.
Vanderbilt researchers have identified a previously undetected type of histone modification that may have implications for cancer and other conditions.
The Sonic hedgehog protein plays a crucial role in the development of brain cells that may be the source of some types of pediatric brain tumors, a recent study reports.
A recent study suggests that a transporter protein called xCT may be potential therapeutic target in lung cancer.
A recent study showing that protein called RADX helps regulate the process of DNA repair may help us better understand why some cancers are more or less resistant to certain therapies
A recent study on how cellular proteins known as “multidrug transporters” work may inform the development of novel anti-cancer and anti-bacterial drugs that can overcome resistance.
A recent study has linked inflammation-driven carcinogenesis in the colon to loss of an important signaling protein called SMAD4.
A new study has identified 48 candidate susceptibility genes for breast cancer risk, including 14 genes at loci (chromosome regions) not yet reported for breast cancer.